| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Exact Sciences Corp (EXAS) has 15 insiders with recent SEC Form 4 filings, including 1 buy and 9 sells. EXAS is classified in the Life Sciences Tools & Services industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| VP | 191.9K | $20.13M | - | |
| VP | 153.7K | $16.13M | - | |
| CFO | 138.7K | $14.55M | - | |
| VP | 137.2K | $14.39M | - | |
| Dir | 34.3K | $3.60M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov 19, 2025 | Herriott James75 | SVP, General Counsel &Sec | Sell | 1,000 | $70.00 | $70,000.00 | -7.9% | +19.9% | - | |
| Nov 19, 2025 | Orville Jacob A76 | EVP, Gm, Screening | Sell | 5,000 | $75.00 | $375,000.00 | -17.7% | +19.9% | - | |
| Nov 4, 2025 | Herriott James75 | SVP, General Counsel &Sec | Sell | 1,500 | $70.08 | $105,120.00 | -10.6% | +47.3% | - | |
| Nov 4, 2025 | Baranick Brian75 | EVP, Gm, Precision Oncology | Sell | 2,858 | $70.08 | $200,288.64 | -11.3% | +47.3% | - | |
| Oct 24, 2025 | Zanotti Katherine S50 | Director | Sell | 12,000 | $65.00 | $780,000.00 | -16.5% | +58.4% | - | |
| Oct 9, 2025 | Doyle James Edward75 | Director | Sell | 2,000 | $60.00 | $120,000.00 | -3.3% | +70.9% | - | |
| Oct 9, 2025 | Herriott James75 | SVP, General Counsel &Sec | Sell | 1,500 | $60.00 | $90,000.00 | -9.6% | +70.9% | - | |
| Aug 13, 2025 | Doyle James Edward75 | Director | Sell | 1,485 | $42.02 | $62,399.70 | -2.4% | +50.3% | - | |
| Jun 13, 2025 | Zanotti Katherine S50 | Director | Sell | 3,207 | $53.20 | $170,612.40 | -4.2% | +4.6% | - | |
| Nov 13, 2024 | Conroy Kevin T81 | President And CEO | Buy | 19,500 | $51.35 | $1,001,325.00 | +1.8% | +0.7% | +33.6% |